Prospective, randomised study with three HRT regimens in postmenopausal women with an intact uterus

Maturitas

Volumn 41, Issue 4, 2002, Pages 289-298

  Mendoza, N ^a   Pison J A ^a   Fernandez M ^a   Sanchez M C ^a   Malde, J ^a   Miranda, J A ^a  

^a Hospital Virgen de las Nievas   (Spain)

Author keywords

HRT regimens; Oestrogen; Postmenopausal women; Tibolone

Indexed keywords

ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; GESTAGEN; PROGESTERONE; TIBOLONE;

ADULT; ANALYSIS OF VARIANCE; ANXIETY NEUROSIS; ARTICLE; CHEMICAL ANALYSIS; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DYSMENORRHEA; FEMALE; FISHER EXACT TEST; HEADACHE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MASTALGIA; MENSTRUAL IRREGULARITY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN IRRITATION; STATISTICAL ANALYSIS; STOMACH PAIN; SYMPTOMATOLOGY; UTERUS; VARICOSIS;

ADMINISTRATION, CUTANEOUS; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NORPREGNENES; PATIENT COMPLIANCE; POSTMENOPAUSE; PROGESTERONE; PROSPECTIVE STUDIES; SAFETY; UTERUS;

MARTES PENNANTI;

EID: 0037171959     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00298-5     Document Type: Article

References (25)

1. Current concepts in estrogen replacement therapy in the menopause
2. International consensus conference on postmenopausal hormone therapy and the cardiovascular system
3. The benefits and risks of hormone replacement therapy: An epidemiologic overview
4. Menopause and hormone replacement therapy: An overview
5. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The PEPI trial
6. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate
7. Estrogen and interrupted progestin: A new concept for menopausal hormone replacement therapy
8. Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal hormone therapy
9. Clinical experience with tibolone over 8 years
10. Comparative clinical evaluation of oestrogen preparations by menopausal and amenorrheal index
11. Estrogen-progestin replacement therapy and endometrial cancer
12. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
13. A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms
14. Tratamiento hormonal sustitutivo: Gestágenos y endometrio
15. Impact on uterine bleeding and endometrial thickness: Tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy
16. Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy
17. Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low dose estrogen or tibolone treatment: A comparison
18. Eficacy, tolerability and rare side effects of tibolone treatment in postmenopausal women
19. Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women
20. Comparison of continuation of postmenopausal hormone replacement therapy: Transdermal versus oral estrogen
21. Women's expectations and acceptance of cyclic induced HRT bleeds
22. Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestogen replacement therapy?
23. Vascular endothelial growth factor in primate endometrium is regulated by oestrogen-receptor and progesteronee-receptor ligands in vivo
24. Enhancing patient compliance with hormone replacement therapy at menopause
25. Livial: A review of clinical studies